We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrudential Regulatory News (PRU)

Share Price Information for Prudential (PRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 723.80
Bid: 723.80
Ask: 724.20
Change: 9.80 (1.37%)
Spread: 0.40 (0.055%)
Open: 725.00
High: 730.00
Low: 720.60
Prev. Close: 714.00
PRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

14 Jan 2022 07:00

RNS Number : 4180Y
Prudential PLC
14 January 2022
 

14 January 2022

 

Prudential plc appoints George Sartorel as a Non-executive Director

 

Prudential plc (Prudential) announces the appointment of George David Sartorel as a Non-executive Director. He joins the Board with effect from 14 January 2022.

 

George Sartorel has extensive experience of China and Southeast Asia gained over his 40-year career in international insurance and was at the forefront of digital transformation during his time with the Allianz Group. George has held a range of senior leadership roles including as Regional CEO of Allianz AG's Asia Pacific business. He also served as a member of the Monetary Authority of Singapore's Financial Centre Advisory Panel from 2015 to 2019.

 

Shriti Vadera, Chair of Prudential plc, said: "I am delighted that George Sartorel is joining the Board as a Non-executive Director. He has considerable expertise in financial services following a long career in the insurance industry. With his extensive operational knowledge of China and Southeast Asia, and his experience of digital transformation, George will be a further invaluable addition to the Board, the composition of which continues to evolve in line with the Group's exclusive focus on Asia and Africa."

 

Media

 

Investors/Analysts

 

Simon Kutner

+44 (0)7581 023 260

Patrick Bowes

+44 (0)20 3977 9702

Ping Ping Tan

+65 9845 8904

William Elderkin

+44 (0)20 3977 9215

 

Notes to Editors

 

About George Sartorel

George David Sartorel has almost 40 years of operational experience in financial services. Mr Sartorel started his career at Manufacturers Mutual Insurance in Australia in 1973 which was acquired by Allianz in 1998. He has held a range of senior roles including General Manager of Allianz Malaysia, Allianz Australia and New Zealand and was responsible for introducing new technology platforms and claims management care models. Between 2005 and 2007, he was the Global Head of Change Programmes for the Allianz Group. In 2007 he became Chief Executive of Allianz Turkey and was appointed CEO of Allianz Italy in 2010. In 2014 Mr Sartorel became Regional CEO of Allianz's Asia Pacific business until 2019 and was a non-executive director of Allianz Australia from September 2019 until August 2021. He was a Founding Director of Allianz X (Allianz's digital investment unit), and the Founder of the Allianz Asia Advisory Council, which he chaired from its inception in 2016 until September 2021. Age 64.

 

Mr Sartorel is a non-executive director of Insurance Australia Group Limited, a company listed on the Australian Securities Exchange.

 

Mr Sartorel holds a Master's degree in International Business Studies from Heriot-Watt University.

 

Shareholding

Mr Sartorel does not hold any interest in any shares of Prudential within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

 

Length of service

Non-executive Directors are usually appointed for an initial three-year term. They are typically expected to serve for two three-year terms, although the Board may invite them to serve for an additional period.

 

Remuneration

Non-executive Directors are not eligible to participate in annual bonus plans, long-term incentive plans or pension arrangements. Their fees are determined by the Board and reflect their individual responsibilities, including committee membership as appropriate.

 

The annual fee for Mr Sartorel at appointment as a Non-executive Director will consist of a basic fee of £99,000.

 

Regulatory disclosures

Mr Sartorel is considered independent for the purposes of the UK Corporate Governance Code and the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (Hong Kong Listing Rules).

 

Mr Sartorel will also join the Board of Prudential Corporation Asia Limited, a wholly-owned subsidiary of Prudential, on 14 January 2022.

 

Save as disclosed above, there is no further information required to be disclosed pursuant to Listing Rule 9.6.13 (1) - (6) of the Listing Rules of the Financial Conduct Authority and Rule 13.51(2) of the Hong Kong Listing Rules.

 

About Prudential plc

Prudential plc provides life and health insurance and asset management, with a focus on Asia and Africa. The business helps people get the most out of life, by making healthcare affordable and accessible and by promoting financial inclusion. Prudential protects people's wealth, helps them grow their assets, and empowers them to save for their goals. The business has more than 17 million life customers in Asia and Africa and is listed on stock exchanges in London, Hong Kong, Singapore and New York. Prudential is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America, nor with The Prudential Assurance Company Limited, a subsidiary of M&G plc, a company incorporated in the United Kingdom.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKNBBNBKBCDD
Date   Source Headline
22nd Apr 20248:34 amRNSNotice of AGM
18th Apr 20249:00 amRNSBLOCK LISTING APPLICATION
12th Apr 202410:01 amRNSDirector/PDMR Shareholding
28th Mar 20241:44 pmRNSDirector/PDMR Shareholding
28th Mar 20249:37 amRNSTotal Voting Rights
27th Mar 20242:34 pmRNSDirector/PDMR Shareholding
27th Mar 20242:28 pmRNSDirector/PDMR Shareholding
27th Mar 202410:08 amRNSOverseas Regulatory Announcement - Grant of Awards
26th Mar 20242:41 pmRNSAnnual Report and Accounts 2023 and Form 20-F
20th Mar 202411:33 amRNSDividend Declaration
20th Mar 202411:33 amRNSPrudential plc – FY23 Results – Additional Info
20th Mar 202411:33 amRNSPrudential plc – FY23 Results – EEV
20th Mar 20248:10 amRNSDividend Declaration
20th Mar 20248:09 amRNSPrudential plc – FY23 Results – Additional Info
20th Mar 20248:08 amRNSPrudential plc – FY23 Results – EEV
20th Mar 20248:03 amRNSPrudential plc – FY23 Results – IFRS
12th Mar 20249:52 amRNSDirector/PDMR Shareholding
29th Feb 202411:08 amRNSTotal Voting Rights
14th Feb 20248:47 amRNSDirector/PDMR Shareholding
31st Jan 20248:53 amRNSTotal Voting Rights
25th Jan 20249:02 amRNSBoard changes
16th Jan 20246:02 pmRNSCompletion of Share Repurchase Programme
16th Jan 20245:56 pmRNSTransaction in Own Shares
15th Jan 20245:45 pmRNSTransaction in Own Shares
12th Jan 20245:49 pmRNSTransaction in Own Shares
11th Jan 20246:04 pmRNSTransaction in Own Shares
11th Jan 20249:53 amRNSDirector/PDMR Shareholding
10th Jan 20246:07 pmRNSTransaction in Own Shares
9th Jan 20245:49 pmRNSTransaction in Own Shares
8th Jan 20245:58 pmRNSTransaction in Own Shares
5th Jan 20248:35 amRNSRepurchase to neutralise share scheme issuance
29th Dec 20238:47 amRNSTotal Voting Rights
20th Dec 20237:00 amRNSPrudential & CITIC provide growth capital for CPL
14th Dec 202310:37 amRNSDirector/PDMR Shareholding
12th Dec 202310:04 amRNSDirector/PDMR Shareholding
30th Nov 202311:54 amRNSTotal Voting Rights
30th Nov 202311:47 amRNSBLOCK LISTING SIX MONTHLY RETURN
16th Nov 20239:17 amRNSBLOCK LISTING APPLICATION
14th Nov 20238:47 amRNSDirector/PDMR Shareholding
6th Nov 20237:19 amRNSPrudential plc - Q3 Business Performance Update
31st Oct 20239:12 amRNSTotal Voting Rights
30th Oct 202311:27 amRNSDirector/PDMR Shareholding
12th Oct 20239:49 amRNSDirector/PDMR Shareholding
9th Oct 20239:44 amRNSDividend Rate Achieved
3rd Oct 202310:31 amRNSOverseas Regulatory Announcement-Grant of Options
3rd Oct 202310:29 amRNSOverseas Regulatory Announcement-Grant of Options
29th Sep 20239:41 amRNSTotal Voting Rights
26th Sep 202310:00 amRNSDirector/PDMR Shareholding
14th Sep 202310:25 amRNS2023 Half-year Report
13th Sep 20239:59 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.